Holen Sie sich die Stockscreener-App
11.49
3.98%
0.44
Handel nachbörslich:
11.55
0.06
+0.52%
Cellebrite Di Ltd Aktie (CLBT) Neueste Nachrichten
Cellebrite (CLBT): CEO Shift and Guidance Cuts Contrast With Surging AI and FedRAMP Gains - Yahoo Finance
Kaplan Fox Launches Securities Probe into Cellebrite DI Ltd (CLBT) Following 29% Stock Plunge and CEO Replacement - Kalkine Media
Cellebrite DI Ltd (CLBT) Faces Securities Investigation After 29% Stock Drop and CEO Change - kalkine.ca
Cellebrite Genesis expands to UK & Australia - SourceSecurity.com
Cellebrite shares plunge over 30% after Q2 reve... - Pluang
Cellebrite DI Ltd. (CLBT) Securities Investigation NoticeLevi & Korsinsky - PR Newswire
Cellebrite Genesis AI Solutions Expand Globally | Security News - Security Informed
Cellebrite (CLBT) Q2 2026 Earnings Call Transcript - The Globe and Mail
Kaplan Fox Announces an Investigation Into Cellebrite DI Ltd. (NASDAQ: CLBT) for Potential Securities Law Violations - The Globe and Mail
Cellebrite Genesis for Enterprise Now Generally Available, Regional Availability Expands to More Global Markets - Japan Wire by Kyodo News
Cellebrite’s New CEO Resets 2026 Outlook After Record 2025 and Calls September Shareholder Meeting - The Globe and Mail
Cellebrite expands Genesis AI tool to enterprise market By Investing.com - Investing.com South Africa
Cellebrite faces securities probe after missing revenue targets and sudden CEO change. - Pluang
Cellebrite DI (CLBT) Stock Falls 29% After ARR Miss and CEO Change, Sparking Securities Investigation - kalkine.ca
Cellebrite DI Says Genesis Platform Now Available to Enterprises, Expands Globally - marketscreener.com
Cellebrite Di Ltd Cellebrite Genesis Is Expanding To More Global Markets And Is Now Generally Available For Enterprise Organizations - TradingView
Cellebrite expands Genesis platform to enterprise and new markets - StreetInsider
Cellebrite (CLBT) officer sets 2026 sell-to-cover for 5,673 shares - Stock Titan
Cellebrite (NASDAQ: CLBT) officer plans tax-driven share sale - Stock Titan
Cellebrite Genesis Expands to Global Markets - Intellectia AI
Cellebrite DI Ltd (CLBT) Stock News Today - TradingKey
Cellebrite (CLBT) Quarterly Figures: Profit Per Share Falls Below Its Benchmark in the Latest Reading; Reaction Snapshot: Shares Finish 5.36% Up at the ClosePre-Announcement Alert - Vinanet
Cellebrite Genesis Expands Internationally - Intellectia AI
Voss Capital reports new stake in Cellebrite (NASDAQ: CLBT) - Stock Titan
Cellebrite (NASDAQ: CLBT) lowers 2026 forecast amid vote on CEO equity plan - Stock Titan
Kaplan Fox Alerts Investors of Cellebrite DI Ltd. (NASDAQ: CLBT) to Possible Securities Law Violations - The National Law Review
Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving Cellebrite DI Ltd. (CLBT) - GlobeNewswire
Cellebrite’s (CLBT) Compounding Track Record Demands Enterprise Software Re-Rating - Yahoo Finance
Cellebrite DI Ltd. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:CLBT) 2026-08-17 - Seeking Alpha
Cellebrite DI (NASDAQ:CLBT) Stock Price Down 6.2% Following Analyst Downgrade - MarketBeat
Why Cellebrite DI (CLBT) Is Down 30.4% After Cutting 2026 Outlook And Announcing CEO Transition - simplywall.st
Cellebrite DI Is Maintained at Buy by DA Davidson - Moomoo
Cellebrite DI Ltd (CLBT) Stock Up 3.1% and Still Undervalued -- GF Score: 84/100 - GuruFocus
Can Cellebrite DI (NASDAQ:CLBT) Regain Market Confidence? - Kalkine Media
Cellebrite (CLBT) Stock Rebounds As ARR Grows But Outlook Cools - simplywall.st
Cellebrite Announces CEO Transition to Shiven Ramji in Planned Succession - The Globe and Mail
Cellebrite DI (NASDAQ:CLBT) Posts Earnings Results, Beats Expectations By $0.06 EPS - MarketBeat
Cellebrite DI (NASDAQ:CLBT) Given New $15.00 Price Target at Lake Street Capital - MarketBeat
CLBT|Cellebrite DI Ltd|Price:11.110|Chg%:+0.310 - TradingKey
Cellebrite Plunges 29% as New CEO Ramji Slashes 2026 Revenue Outlook - finance.biggo.com
Kaplan Fox is Investigating Cellebrite DI Ltd. (NASDAQ: CLBT) for Potential Securities Law Violations - The Globe and Mail
Cellebrite DI (NASDAQ:CLBT) Given New $16.00 Price Target at JPMorgan Chase & Co. - MarketBeat
Legal Tech Roundup: Cellebrite, LexisNexis - Law360
Cellebrite DI (NASDAQ:CLBT) Sees Unusually-High Trading Volume After Strong Earnings - MarketBeat
DA Davidson Has Lowered Expectations for Cellebrite DI (NASDAQ:CLBT) Stock Price - MarketBeat
Cellebrite DI Ltd. (CLBT) Edges Higher on Steady Demand for Digital Intelligence SolutionsIchimoku Cloud - Vinanet
Cellebrite DI (CLBT) Cuts Guidance And Changes CEO, Is The Stock Now Cheap? - Yahoo Finance
CLBT SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Cellebrite DI Ltd. - PR Newswire
Cellebrite DI (NASDAQ:CLBT) Given New $12.50 Price Target at Needham & Company LLC - MarketBeat
Needham cuts Cellebrite stock price target on guidance reduction By Investing.com - Investing.com South Africa
Needham cuts Cellebrite stock price target on guidance reduction - Investing.com
Deutsche Bank Adjusts Cellebrite DI Price Target to $14 From $20, Maintains Buy Rating - marketscreener.com
Does Cellebrite DI’s Lowered 2026 Outlook and New CEO Reset Its AI Narrative (CLBT)? - Yahoo Finance
Cellebrite DI Insider Sold Shares Worth $2,149,638, According to a Recent SEC Filing - marketscreener.com
Cellebrite Q2 2026 slides: AI ambitions meet execution hurdles By Investing.com - Investing.com South Africa
ETFs Investing in Cellebrite DI Ltd. Stocks - TradingView
Cellebrite DI (CLBT) Names Shiven Ramji As Next CEO - Yahoo Finance
Cellebrite DI Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Cellebrite DI (CLBT) - Morningstar
Cellebrite shares plunge 30% after Q2 revenue m... - Pluang
1.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):